New Zealand - Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung
Since 2014, New Zealand Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung decreased by 0.8% year on year. In 2019, the country was number 17 comparing other countries in Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung at 9.3 Days. Costa Rica topped the ranking with 14.1 Days in 2019, that is a growth of 6.8% compared to 2018. South Korea, Portugal and Ireland respectively ranked number 2, 3 and 4 in this ranking. Costa Rica witnessed the best average annual growth at +2.8% per year, while Mexico was the worst growing country at -6.2% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 9.30 |
| 2018 | 9.40 |
| 2017 | 9.50 |
| 2016 | 9.30 |
| 2015 | 11.40 |
Download all data from 1980 to 2019
How does New Zealand rank in Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Costa Rica
|
14.10 | 2019 | +6.8 % | +2.8 % | View data | |
| 2 |
#2
South Korea
|
13.70 | 2019 | -0.7 % | -0.1 % | View data | |
| 14 |
#14
United Kingdom
|
9.80 | 2019 | +0.0 % | -1.4 % | View data | |
| 17 |
#17
New Zealand
|
9.30 | 2019 | -1.1 % | -0.8 % | View data | |
| 18 |
#18
Sweden
|
8.80 | 2019 | +0.0 % | -1.9 % | View data | |